Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
FDA Adds Heart Disease Risk, Diabetes Warning to Prostate Cancer Drugs October 21, 2010 Staff Writers Add Your Comments Federal drug regulators are calling for new heart disease and diabetes warnings to be added to a class of prostate cancer drugs that includes Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex. On Wednesday, the FDA issued a drug safety alert, announcing that it was asking manufacturers to add the new warnings to all drugs belonging to a class known as gonadotropin-releasing hormone (GnRH) agonists. The warnings will alert patients and doctors that side effects of the drugs may include a small increased risk of diabetes and cardiovascular events, including heart attacks and strokes. The FDA launched a safety review of GnRH agonists in May. That review is ongoing. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Before the call for new label warnings, the FDA had already recommended that health care professionals be made aware of the potential risks and carefully weigh those risks before prescribing the drugs. The agency also recommended that patients prescribed a GnRH be monitored for diabetes and cardiovascular disease, and that cardiovascular risk factors, such as smoking and high blood pressure, be controlled while taking the medication. The FDA also warned patients not to stop treatment with GnRH’s unless instructed by their health care provider. GnRH’s suppress the production of testosterone, limiting the ability of prostate cancer to grow. The class of drugs includes Sanofi-Aventis’s Eligard, Abbott Laboratories’ Lupron, and Pfizer’s Synarel, among other brand names, as well as generic products. The drugs are also often used to treat women suffering from pain caused by endometriosis, and to treat anemia and breast cancer. It is also used in children to treat central precocious puberty. However, these uses have not been approved by FDA. The FDA estimates that there will be 217,730 new cases of prostate cancer among men this year, and that it will kill about 32,050 men, making it the second most common type of cancer among men in the U.S., behind skin cancer. Tags: Cancer, Diabetes, Eligard, Heart Attack, Heart Disease, Lupron, Pfizer, Prostate Cancer, Sanofi-Aventis, Stroke, Synarel, Trelstar, Vantas, Viadur, Zoladex More Lawsuit Stories Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 January 27, 2026 Big Toe Fusion Lawsuit Filed Over Failed Cartiva SCI Implant January 27, 2026 Study Questions Link Between Side Effects of Nexium, Prilosec and Stomach Cancer January 27, 2026 2 Comments Petal November 11, 2010 Hello, My name is Petal J. from Trinidad. West Indies. I have had surgery in April 2008 for the removal of fibroid and my doctor insisted that I took the product Zoladex for six months. At the time I was 33 years old and I had gone thru menopause during the time I was taking the Zoladex. I had hot flashes, no period for six months etc. At present I am 35 years old and due to taking the product I have had rapid weight gain. I am 190 lbs fighting an obesity a problem I have never had before. All these things happened due to the fact that I have been injected for six months with the Zoladex product in 2008. Arthur October 23, 2010 I am a Bahamian. About a year ago I was advised that there was a tiny nodule on my prostate and my PSA level had risen to about 12. A biopsy performed in Orlando, Fla indicated Stage 2 cancer, which I was told was treatable. Prior to this, and starting radiation treatment, I was able to reduce the PSA count to 1.2 after using a suppository produced by a local urologist, Dr Joseph Evans, marketed under the brand name Navophos, although I was later informed that the active ingredient – afemale hormone- which I can’t recall at the moment, had been touted in a New York Times 1941 article as a breakthrough cure for cancer. At a local cancer forum, I was advised that “the cure” had been ordered withdrawn due to an association with heart attic susceptibility. On entering the local health system I was advised that I needed to switch to Zoladex in order to comply with eligibility requirements and also the fact that although ‘Navophos’ had been inquired about, it was not clear how it would impact the radiation treatment. After completing the radiation treatment, I was advised to have a new PSA test before a post-treatment assessment. However, at the time of the ‘post-treatment’ exam, I was advised that the result of the new PSA test had not been received and there would be no rectal exam as the effect of the radiation had probably left the area too sensitive for any ‘probing’, but I would be contacted about the results of the PSA test. After not being contacted after about three weeks I visited the local cancer radiation therapy centurion FridayOct 22 and was told the PSA test result had not yet been received and to check back the following week. Prior to this I visited my local GP and was told that my blood pressure, which had consistently been normal, was now somewhat lower. My occasional mild perspiring was attributed to ‘hot flashes’ as a result of the Zoladex. I am now awaiting the result of the PSA test. Another doctor has suggested that if it was him, he would have stayed on the Navophos even though it tended to leave one’s breasts in a somewhat ‘tender’ state. Apart from awaiting the results and any commentary about the PSA test, my next appointment with the radiation centre is in mid Jan 2011. Apart from the above, I still feel reasonably physically healthy. My urologist has advised that while the radiation therapy has an approximately 70% cure rate, additional hormonal therapy treatment increases this to about 90%. CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: today) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025) Abbott Eterna Spinal Cord Stimulator Lawsuit Filed Over Lead Migration, Device Malfunction (Posted: yesterday) A spinal cord stimulator lawsuit claims an Abbott Eterna device failed after only two months due to lead migration. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Spinal Cord Stimulator Lawsuit Claims Lead and Battery Problems Led to Multiple Revision Surgeries (10/22/2025)Medtronic Spinal Cord Stimulator Lawsuit Alleges Device Worsened Pain (04/30/2025)FDA Tells Doctors To Conduct Trial Stimulation Test Before Using Spinal Cord Stimulators (09/04/2020) Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: 4 days ago) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)
Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 January 27, 2026
Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: today) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)
Abbott Eterna Spinal Cord Stimulator Lawsuit Filed Over Lead Migration, Device Malfunction (Posted: yesterday) A spinal cord stimulator lawsuit claims an Abbott Eterna device failed after only two months due to lead migration. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Spinal Cord Stimulator Lawsuit Claims Lead and Battery Problems Led to Multiple Revision Surgeries (10/22/2025)Medtronic Spinal Cord Stimulator Lawsuit Alleges Device Worsened Pain (04/30/2025)FDA Tells Doctors To Conduct Trial Stimulation Test Before Using Spinal Cord Stimulators (09/04/2020)
Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: 4 days ago) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)